Nervous System Channel
Topics
Medications
Quicklinks
Related Channels
What Is Benztropine Used For?
Benztropine is used for relieving symptoms of Parkinson's disease and certain movement disorders (extrapyramidal disorders) that are caused by antipsychotic medications. As an anticholinergic medication, benztropine works by re-establishing the balance of certain chemicals in the nervous system. Occasionally, healthcare providers may also prescribe benztropine "off-label" to treat excess salivation ("drooling").
Interested in a Discount on Benztropine?
Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).
Thank you!
Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.
Benztropine mesylate (Cogentin®) is a prescription medication. The drug belongs to a group of medicines known as anticholinergics and is approved to treat the following conditions:
- Extrapyramidal disorders (movement or muscle tension disorders) caused by antipsychotic medications
- Parkinson's disease and other similar conditions (when used in combination with other medications).
Extrapyramidal symptoms (also known as EPS) are a set of side effects that are common with antipsychotic medications, as well as a few other types of medications. Extrapyramidal symptoms are usually divided into different categories. Dyskinesias are movement disorders, while dystonias are muscle tension disorders. "Tardive" symptoms are those that appear during long-term treatment (often after several years of treatment). Unlike earlier symptoms, tardive symptoms are more likely to be permanent, even after the medication is stopped.
Benztropine can be very effective at controlling most EPS. However, benztropine should not be used to treat tardive dyskinesia, as it is not effective for this use and may even worsen the condition.
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD